SEC Tracker
Get the app
BDX · XBRL financial data

Becton, Dickinson and Company financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (BDX's year ends in late September)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue5,087*4,7065,0454,9905,437*5,1685,2725,5095,891*5,2524,7144,983
Cost of goods and services sold3,386*2,6792,7412,6832,950*2,9333,0152,8753,092*2,8412,5602,668
Research and development281*290299299302*343302297322*306249258
Selling, general and administrative1,138*1,2131,1931,1961,256*1,3181,2731,3201,366*1,3931,2131,261
Other operating income (expense)203*(11)23(98)(136)*(28)(45)(38)(285)*(50)(66)(44)
Operating income (loss)349*439734602622*453546882697*55293663
Interest income9*34264855*23555*494
Interest expense113*111125137155*155151152155*153149132
Other income (expense)(64)*(4)(2)(13)(9)*(16)(38)(33)(37)*(10)8619
Income tax expense (benefit)28*779613114*35512917*1176102
Net income (loss)108*281537487400*303308574493*382(311)377
Earnings per share, basic USD per share0.37*0.971.851.681.38*1.051.072.001.72*1.34(1.11)1.37
Earnings per share, diluted USD per share0.37*0.961.851.681.37*1.041.072.001.71*1.34(1.11)1.37
Weighted average shares, basic millions of shares291*290290290290*290287287287*286281275
Weighted average shares, diluted millions of shares295*291290290292*290288287289*286281275

Balance sheet

CSV

Fiscal quarters (BDX's year ends in late September)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents1,4161,1802,3484,4591,717711667735641740813708
Accounts receivable2,5342,2672,5592,5963,0332,6383,0292,9432,9942,5082,2052,364
Inventory3,2733,3043,2293,2553,8433,8603,7233,9493,8944,0853,3573,316
Total current assets8,6768,15610,34012,20710,4688,6598,6668,9979,2559,1898,0128,139
Property and equipment, net6,5576,6476,5916,5186,8216,6026,6466,8186,9976,9726,0826,083
Right-of-use asset517———876———885———
Goodwill24,52224,59724,56624,54626,46526,32926,44426,59726,61226,62025,95525,944
Total assets52,78052,27454,15755,58257,28654,66554,46754,90255,32554,84150,83250,731
Accounts payable1,641———1,896———1,974———
Accrued liabilities2,604———3,476———3,103———
Total current liabilities6,6417,5407,3276,6058,9567,6647,6918,1608,3138,7618,5079,404
Long-term debt14,73814,09415,99518,13117,94017,44017,66617,53117,62116,91614,70613,511
Lease liability, non-current414———667———704———
Retained earnings15,53515,54015,80216,01516,13916,14116,15016,42616,62216,70417,39117,509
Total stockholders' equity25,79625,33225,64725,86825,89025,20525,24125,47225,39025,28224,13324,416
Total liabilities and equity52,78052,27454,15755,58257,28654,66554,46754,90255,32554,84150,83250,731
Common shares outstanding (cover page) millions of shares290289289289289287287287285285276272

Cash flows

CSV

Fiscal quarters (BDX's year ends in late September)

In millions of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)108*281537487400*303308574493*382(311)377
Stock-based compensation58*8360*53*51*9059*54*55*9158*55*
Depreciation and amortization587*561571*568*586*607567575629*614563564
Net cash from operating activities—————693———657——
Purchases of property and equipment294*116134*179*296*105129*174*352*108125*143*
Net cash from investing activities137*(233)(1,056)*(288)*(3,937)*204(192)*(336)*(494)*(183)——
Share repurchases0*5000*0*0*7500*0*250*2502,000*0*
Dividends paid265*275275*275*275*302298*299*297*299290*286*
Proceeds from long-term debtyear only———year only———year only———
Repayments of long-term debt439*00*1,142*0*8751*333*580*02,0002,000
Net cash from financing activities(997)*(862)1,705*1,120*124*(1,928)(39)*(841)*(809)*(302)——
Net change in cash456*(247)1,160*2,093*(2,631)*(1,043)(66)*51*53*17464*(152)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Becton Dickinson7084,983not reported272.4M 10-QJun 30, 2026
3M4,8356,584486*516.7M 10-QSep 30, 2026
Edwards Lifesciences2,9071,741652*576.4M 10-QJun 30, 2026
Medtronic1,6919,7561,7931.3B 10-QJul 31, 2026
Resmed1,0111,415422140.7M 10-QSep 30, 2026
Dexcom9611,345326*373.0M 10-QSep 30, 2026
GE HealthCare Technologies2,8265,513907*452.1M 10-QSep 30, 2026
Stryker3,2716,5201,461*380.7M 10-QSep 30, 2026
Boston Scientific6095,1381,048*1.4B 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.